참고문헌
- "About diabetes", World Health Organization, 31 March 2014.
- "IDF diabetes atlas", Brussels: International Diabetes Federation, 7th Edition, 2015, http://diabetesatlas.org.
- World Health Organization, "Health topics. Diabetes. Fact sheet n 312", Reviewed October 2013.
- M. E. Cerf, "Beta cell dysfunction and insulin resistance", Front. Endocrinol., Vol. 4, 2013.
-
Y. Sahisgo, "
${\beta}$ -Cell dysfunction: its critical role in prevention and management of type 2 diabetes", World J. Diabetes, Vol. 6, pp.109-124, 2015. https://doi.org/10.4239/wjd.v6.i1.109 - N. K. Tonks, "PTP1B: from the sidelines to the front lines!", FEBS Lett., Vol. 546, pp. 140-148, 2003. https://doi.org/10.1016/S0014-5793(03)00603-3
- H. Cho, "Protein tyrosine phosphatase 1B (PTP1B) and obesity", Vitam. Horm., Vol. 91, pp. 405-424, 2013.
- J. Montalibet and B. P. Kennedy, "Therapeutic strategies for targeting PTP1B in diabetes", Drug Discov. Today. Ther. Strateg., Vol. 2, pp. 129-135, 2005. https://doi.org/10.1016/j.ddstr.2005.05.002
- Z.-Y. Zhang and S.-Y. Lee, "PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity", Expert Opin. Investig. Drugs, Vol. 12, pp. 223-s233, 2003. https://doi.org/10.1517/13543784.12.2.223
- A. M. Patel, I. S. Anand, and M. A. Suva, "Role of protein tyrosine phosphatase-1B inhibitors in type 2 diabetes mellitus", J. PharmSciTech, Vol. 4, pp.1-5, 2014.
- F. Perveen, R. Qureshi, F. L. Ansari, S. Kalsoom, and S. Ahmed, "Investigations of drug-DNA interactions using molecular docking, cyclic voltammetry and UV-Vis spectroscopy", J. Mol. Struct., Vol. 1004, pp. 67-73, 2011. https://doi.org/10.1016/j.molstruc.2011.07.027
- B. Sathya, "Molecular docking study of naturallyderived neuraminidase inhibitors isolated from phellinus baumii", J. Chosun Natural Sci., Vol. 8, pp. 209-213, 2015. https://doi.org/10.13160/ricns.2015.8.3.209
- M. Thirumurthy, "A docking study of newly found natural neuraminidase inhibitor: erystagallin A", J. Chosun Natural Sci., Vol. 4, pp. 273-277, 2011.
- C. G. Gadhe, "Comparative modeling of human Pgp NBD2 and docking and binding mode analysis of 8-geranyl chrysin as a P-gp modulator", J. Chosun Natural Sci., Vol. 5, pp. 18-21, 2012. https://doi.org/10.13160/ricns.2012.5.1.018
- SYBYL Software, Tripos Associates Inc, St. Louis, USA, 2006.
- The PyMOL Molecular Graphics System, Version 1.7.4 Schrodinger, LLC.
- C. N. Nguyen, B. T. D. Trinh, T. B. Tran, L.-T. Nguyen, A. K. Jager, and L. D. Nguyen, "Anti-diabetic xanthones from the bark of Garcinia xanthochymus", Bioorg. Med. Chem. Lett, Vol. 27, pp. 3301-3304, 2017. https://doi.org/10.1016/j.bmcl.2017.06.021
- A. N. Jain, "Scoring functions for protein-ligand docking", Curr. Protein Pept. Sci., Vol. 7, pp. 407-420, 2006. https://doi.org/10.2174/138920306778559395
- A. N Jain, "Scoring non-covalent protein-ligand interactions: a continuous differentiable function tuned to compute binding", J. Comput. Aided Mol. Des., Vol. 10, pp. 427-440, 1996. https://doi.org/10.1007/BF00124474